Levvy Lv
Corporate Officer/Principal bei LIANBIO
Ursprung des Netzwerks ersten Grades von Levvy Lv
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
17
| Public Company | Biotechnology | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Levvy Lv
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Rotman School of Management | College/University | Masters Business Admin | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| KADMON HOLDINGS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Undergraduate Degree | |
| University of London | College/University | Undergraduate Degree | |
| New York University | College/University | Masters Business Admin Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| Purdue University | College/University | Graduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Graduate Degree | |
| State University of New York at Albany | College/University | Graduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
GlaxoSmithkline Ltd.
 GlaxoSmithkline Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Ltd. is a company based in Hong Kong, Hong Kong. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer Corporate Officer/Principal | |
Solebury Strategic Communications LLC
 Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Endurance Advisors LLC
 Endurance Advisors LLC Investment ManagersFinance Endurance Advisors LLC provides investment advisory services. The private company is based in San Francisco, CA. The company was founded by Peter Rahmer. | Investment Managers | Corporate Officer/Principal | |
| MEIRAGTX HOLDINGS PLC | Biotechnology | Director/Board Member Investor Relations Contact | |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | President | |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | President | |
Phoenix Tissue Repair, Inc.
 Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Phoenix Tissue Repair, Inc. develops biopharmaceuticals. The company is based in Boston, MA. | Pharmaceuticals: Major | President | |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Founder | |
| Adrenas Therapeutics, Inc. | Treasurer | ||
| BridgeBio Services, Inc. | Chief Executive Officer | ||
| Calcilytix Therapeutics, Inc. | President | ||
| ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Founder Founder | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Director/Board Member Founder Founder | |
Prolaio, Inc.
 Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ. | Biotechnology | President Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 40 |
| Vereinigtes Königreich | 4 |
| China | 3 |
| Kanada | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 14 |
| Finance | 10 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 51 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 19 |
| Undergraduate Degree | 16 |
| Chief Executive Officer | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Debra Yu | 21 |
| Neil Kumar | 18 |
| Adam Stone | 17 |
| Konstantin Poukalov | 15 |
| Tassos Gianakakos | 10 |
| Susan Silbermann | 10 |
| Jen Wei Wu | 9 |
| Wei Wei Chen | 7 |
| Yi Larson | 7 |
| Nathan Chen | 6 |
| Elizabeth Anderson | 6 |
| Michael Humphries | 6 |
| Yi Zhe Wang | 5 |
| Brianne Jahn | 5 |
| Pascal Qian | 5 |
